Literature DB >> 28978255

Will the presence of the patient at multidisciplinary meetings influence the decision in head and neck oncology management?

Julie Massoubre1, Michel Lapeyre2, Rémy Pastourel1, Vincent Dupuch1, Julian Biau2, Anne-Francoise Dillies3, Thierry Mom1, Bruno Pereira4, Laurent Gilain1, Nicolas Saroul1.   

Abstract

OBJECTIVES: Multidisciplinary team meetings (MTM) are essential in the choice of a therapeutic strategy in head and neck cancer. In many centres patients attend MTMs and are examined by the team. The aim of this study was to assess the influence of the patient's presence on therapeutic decisions. STUDY
DESIGN: Prospective study of 119 consecutive patients.
METHODS: Two therapeutic situations were compared: the therapeutic decision taken following discussion of the patient's file in the MTM (D1) and the therapeutic decision taken after examination of the patient during MTMs (D2). Concordance between the two situations was measured.
RESULTS: Concordance between D1 and D2 was 97%. No factors likely to decrease concordance were identified. Decisions taken during MTMs were acted upon for 97% of the patients.
CONCLUSION: The presence of the patient during MTMs is not essential if the files are thoroughly presented and discussed.

Entities:  

Keywords:  Head and neck cancer; multidisciplinary team meetings; presence of the patient; therapeutic decision

Mesh:

Year:  2017        PMID: 28978255     DOI: 10.1080/00016489.2017.1384059

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations.

Authors:  Mahalakshmi S Rangabashyam; Shi Yan Lee; Sher Yin Tan; Stefan Mueller; Rehena Sultana; Johnatton Ho; Thakshayeni Skanthakumar; Ngian Chye Tan; Hiang Khoon Tan; Khee Chee Soo; N Gopalakrishna Iyer
Journal:  Cancer Med       Date:  2020-05-30       Impact factor: 4.452

2.  Patient Participation in Multidisciplinary Tumor Conferences from the Providers' Perspective: Is It Feasible in Routine Cancer Care?

Authors:  Christian Heuser; Annika Diekmann; Barbara Schellenberger; Barbara Bohmeier; Walther Kuhn; Ute Karbach; Nicole Ernstmann; Lena Ansmann
Journal:  J Multidiscip Healthc       Date:  2020-11-27

3.  Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review.

Authors:  Janneke E W Walraven; Olga L van der Hel; J J M van der Hoeven; Valery E P P Lemmens; Rob H A Verhoeven; Ingrid M E Desar
Journal:  BMC Health Serv Res       Date:  2022-06-27       Impact factor: 2.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.